One of the prominent economic debates to emerge during the coronavirus outbreak has been about how long to continue with shelter-in-place measures that are hurting the economy but, hopefully, slowing ...

For years, the Obama and Biden administrations have relied on the social cost of carbon in shaping energy policy. They ...

The latest report from the United Nations’ Intergovernmental Panel on Climate Change is stark. U.N. Secretary-General António Guterres describes it as “an atlas of human suffering and a damning ...

There's little doubt that the use of taxpayer-funded incentives will remain the subject of intense disagreement among public officials, researchers and the public. Regardless of the larger debate, ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Health economics provides a framework for evaluating the allocation of limited resources in healthcare, ensuring that interventions not only deliver clinical benefit but also represent optimal use of ...

The Association of American Railroads (AAR) on March 14 petitioned the Surface Transportation Board (STB) to incorporate cost-benefit analysis into rulemaking proceedings. AAR urged that, “in the ...

If a tree stands in the forest, and there’s no economist around to tabulate its benefits to humans, do those benefits still exist? Critically, the healthier our natural environment, the more — and ...

On his very first day in office President Joe Biden issued a memorandum directing the Office of Management and Budget (OMB) to make “recommendations for improving and modernizing regulatory review.” ...

ON SEPT. 18, 2015, the US Environmental Protection Agency published a new proposed rule to regulate methane gas emission from the oil and gas sector. The new rule would expand EPA's current volatile ...

The Environmental Protection Agency has published and solicited public comments on its draft rule reforming the benefit/cost analytic methodology applied to new regulations promulgated under the Clean ...

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...